Sec Form 4 Filing - Rogers Erica J. @ Silk Road Medical Inc - 2019-04-08

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Rogers Erica J. 2. Issuer Name and Ticker or Trading Symbol Silk Road Medical Inc [ SILK] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) President and CEO (Last) (First) (Middle) C/O SILK ROAD MEDICAL, INC., 1213 INNSBRUCK DRIVE 3. Date of Earliest Transaction (MM/DD/YY) 04/08/2019 (Street) SUNNYVALE, CA94089 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 04/08/2019 C 9,012 A 82,706 I See Footnote ( 2 ) Common Stock 04/08/2019 C 1,137 A 83,843 I See Footnote ( 2 ) Common Stock 96,296 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series C Preferred Stock ( 1 ) 04/08/2019 C 9,012 ( 1 ) ( 1 ) Common Stock 9,012 $ 0 0 I See Footnote ( 2 ) Series C Preferred Stock Warrant (Right to buy) $ 6.11 04/08/2019 X( 3 ) 1,638 ( 4 ) 10/13/2023 Common Stock 1,638 $ 0 0 I See Footnote ( 5 ) Series C Preferred Stock ( 1 ) 04/08/2019 X( 3 ) 1,638 ( 1 ) ( 1 ) Common Stock 1,638 $ 0 1,638 I See Footnote ( 2 ) Series C Preferred Stock ( 1 ) 04/08/2019 J( 3 ) 501 ( 1 ) ( 1 ) Common Stock 501 $ 0 1,137 I See Footnote ( 2 ) Series C Preferred Stock ( 1 ) 04/08/2019 C 1,137 ( 1 ) ( 1 ) Common Stock 1,137 $ 0 0 I See Footnote ( 2 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Rogers Erica J. C/O SILK ROAD MEDICAL, INC. 1213 INNSBRUCK DRIVE SUNNYVALE, CA94089 X President and CEO Signatures /s/ Mhairi Jones, by power of attorney 04/10/2019 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. ( 2 )These shares are held directly by Kevin J. Surace and Erica J. Rogers, as Trustees of The Surace/Rogers Family Trust (the "Surace/Rogers Family Trust"). ( 3 )The Surace/Rogers Family Trust exercised a warrant to purchase 1,638 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. The Surace/Rogers Family Trust paid the exercise price on a cashless basis, resulting in the Issuer withholding 501 of the warrant shares to pay the exercise price and issued to The Surace/Rogers Family Trust the remaining 1,137 shares. ( 4 )All of the shares subject to the warrant are fully exercisable as of the date hereof. ( 5 )This warrant is held by the Surace/Rogers Family Trust.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.